Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sanae Yasuda
Observed names:
S Yasuda,
S. Yasuda,
Sanae YASUDA
Institutions:
Eisai (United States),
Eisai (Japan)
Observed institutions:
Tokyo University of Science,
Tohoku University,
Eisai (United States),
Japan Pharmaceutical Manufacturers Association,
National Cancer Center Hospital,
Eisai (Japan)
show all 6
OpenAlex ID:
A5112563298
Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4′-hydroxylation status
1995
·
Sanae Yasuda
, Yukio Horai
, et al.
·
Clinical Pharmacology & Therapeutics
·
139
Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation*
1995
·
Takashi Ishizaki
, Kan Chiba
, et al.
·
Clinical Pharmacology & Therapeutics
·
81
Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers.
1994
·
S Yasuda
, A Ohnishi
, et al.
·
PubMed
·
80
Two lactone formation reactions from 1,3-dioxin-4-ones having hydroxyalkyl group at the 6-position: Difference in ring opening and closure
1991
·
Masayuki Sato
, Jun-ichi Sakaki
, et al.
·
Tetrahedron
·
53
Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease
2022
·
Seiichi Hayato
, Osamu Takenaka
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
46
PDF
Determination of a new H+—K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography
1994
·
H. Nakai
, Y. Shimamura
, et al.
·
Journal of Chromatography B Biomedical Sciences and Applications
·
44
Concentration–Response Modeling of ECG Data From Early‐Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk — Experience From the Development Program of Lemborexant
2016
·
Patricia J. Murphy
, Sanae Yasuda
, et al.
·
The Journal of Clinical Pharmacology
·
35
Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
2005
·
Yasuhide Yamada
, Noboru Yamamoto
, et al.
·
Cancer Science
·
34
A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease
2023
·
Hugo Geerts
, Mike Walker
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
29
PDF
Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs
2018
·
Maiko Nomoto
, Cynthia A. Zamora
, et al.
·
British Journal of Clinical Pharmacology
·
28
Population pharmacokinetics and exposure–response analyses of safety ( ARIA ‐E and isolated ARIA ‐H) of lecanemab in subjects with early Alzheimer's disease
2024
·
Oneeb Majid
, Youfang Cao
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
22
PDF
Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
1999
·
S Yasuda
, S Higashi
, et al.
·
PubMed
·
20
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects
2023
·
Shan Jing
, Sari Shiba
, et al.
·
Clinical Drug Investigation
·
14
PDF
Pharmacokinetics of Perampanel in Healthy Korean, White, and Japanese Adult Subjects
2018
·
Hiroko Tabuchi
, Sari Shiba
, et al.
·
Clinical Pharmacology in Drug Development
·
14
Modeled Impact of APOE4 Genotype on ARIA‐E Incidence in Patients Treated With Lecanemab
2022
·
Larisa Reyderman
, Seiichi Hayato
, et al.
·
Alzheimer s & Dementia
·
7
Stereoselective inhibition of CYP2D6 by chlorpheniramine
1995
·
Julio Salcedo
, Sanae Yasuda
, et al.
·
Clinical Pharmacology & Therapeutics
·
7
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
2020
·
Sari Shiba
, Hisakuni Sekino
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
6
PDF
Pharmacokinetic and Exposure–Response Modeling Support Body Surface Area‐Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors
2025
·
Seiichi Hayato
, Lora Hamuro
, et al.
·
The Journal of Clinical Pharmacology
·
5
PDF
Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC)
2024
·
Oneeb Majid
, Seiichi Hayato
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
4
P1‐040: Elenbecestat, a Novel Bace Inhibitor, Demonstrates Similar Pharmacokinetics and Tolerability in Japanese Subjects With Multiple Dosings
2018
·
Nozomi Hayata
, Sanae Yasuda
, et al.
·
Alzheimer s & Dementia
·
4
Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T‐Cell Lymphoma
2025
·
Theingi M. Thway
, Jagadeesh Aluri
, et al.
·
Clinical and Translational Science
·
3
PDF
Safety, pharmacokinetics, and pharmacodynamics in first-in-human study of a novel compound E6742, a Toll-like receptor 7 and 8 antagonist
2018
·
Kenya Nakai
, Sanae Yasuda
, et al.
·
Proceedings for Annual Meeting of The Japanese Pharmacological Society
·
3
PDF
Dose optimization for MORAb-202, an antibody-drug conjugate (ADC) highly selective for folate receptor-alpha (FRα), using population pharmacokinetic (PPK) and exposure-response (E-R) efficacy and safety analyses.
2022
·
Seiichi Hayato
, Lora Hamuro
, et al.
·
Journal of Clinical Oncology
·
2
Abstract PS12-15: Pharmacokinetics of H3B-6545 in patients with locally advanced or metastatic estrogen receptor-positive HER2 negative breast cancer (ER+ and HER2- BC)
2021
·
Oneeb Majid
, Jianjun Alan Xiao
, et al.
·
Cancer Research
·
2
Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor
2024
·
Maiko Nomoto
, Tomoko Hasunuma
, et al.
·
The Journal of Clinical Pharmacology
·
1
PDF
Show more works
View as search
Works count:
36
Citation count:
687
H-index:
14
I10-index:
14
Year
Topic
Type